BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30831262)

  • 1. Strategies for the discovery of biased GPCR ligands.
    Bermudez M; Nguyen TN; Omieczynski C; Wolber G
    Drug Discov Today; 2019 Apr; 24(4):1031-1037. PubMed ID: 30831262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?
    Madariaga-Mazón A; Marmolejo-Valencia AF; Li Y; Toll L; Houghten RA; Martinez-Mayorga K
    Drug Discov Today; 2017 Nov; 22(11):1719-1729. PubMed ID: 28743488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biasing GPCR signaling from inside.
    Shukla AK
    Sci Signal; 2014 Jan; 7(310):pe3. PubMed ID: 24473194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
    Tan L; Yan W; McCorvy JD; Cheng J
    J Med Chem; 2018 Nov; 61(22):9841-9878. PubMed ID: 29939744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4 biased small molecule modulators.
    Lin C; Wang H; Zhang M; Mustafa S; Wang Y; Li H; Yin H; Hutchinson MR; Wang X
    Pharmacol Ther; 2021 Dec; 228():107918. PubMed ID: 34171331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent updates on GPCR biased agonism.
    Pupo AS; Duarte DA; Lima V; Teixeira LB; Parreiras-E-Silva LT; Costa-Neto CM
    Pharmacol Res; 2016 Oct; 112():49-57. PubMed ID: 26836887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
    Luttrell LM; Maudsley S; Bohn LM
    Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor.
    Thompson GL; Lane JR; Coudrat T; Sexton PM; Christopoulos A; Canals M
    Biochem Pharmacol; 2016 Aug; 113():70-87. PubMed ID: 27286929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing biased responses of GPCR ligands.
    Benredjem B; Dallaire P; Pineyro G
    Curr Opin Pharmacol; 2017 Feb; 32():71-76. PubMed ID: 27930943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.
    Slosky LM; Caron MG; Barak LS
    Trends Pharmacol Sci; 2021 Apr; 42(4):283-299. PubMed ID: 33581873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biased ligands: pathway validation for novel GPCR therapeutics.
    Rominger DH; Cowan CL; Gowen-MacDonald W; Violin JD
    Curr Opin Pharmacol; 2014 Jun; 16():108-15. PubMed ID: 24834870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into biased agonism at G protein-coupled receptors and their potential for drug design.
    Martí-Solano M; Guixà-González R; Sanz F; Pastor M; Selent J
    Curr Pharm Des; 2013; 19(28):5156-66. PubMed ID: 23621547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
    DeWire SM; Violin JD
    Circ Res; 2011 Jul; 109(2):205-16. PubMed ID: 21737816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery.
    Zou Y; Ewalt J; Ng HL
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput screening (HTS) in identification new ligands and drugable targets of G protein-coupled receptors (GPCRs).
    Wang D; Li Y; Zhang Y; Liu Y; Shi G
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):232-41. PubMed ID: 22221056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs.
    McCorvy JD; Butler KV; Kelly B; Rechsteiner K; Karpiak J; Betz RM; Kormos BL; Shoichet BK; Dror RO; Jin J; Roth BL
    Nat Chem Biol; 2018 Feb; 14(2):126-134. PubMed ID: 29227473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies and considerations of G-protein-coupled receptor photopharmacology.
    Berizzi AE; Goudet C
    Adv Pharmacol; 2020; 88():143-172. PubMed ID: 32416866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.